Related references
Note: Only part of the references are listed.Safety and antibody response to inactivated COVID-19 vaccine in patients with chronic hepatitis B virus infection
Taiyu He et al.
LIVER INTERNATIONAL (2022)
Safety and immunogenicity of SARS-CoV-2 vaccines in Chinese patients with cirrhosis: a prospective multicenter study
Jitao Wang et al.
HEPATOLOGY INTERNATIONAL (2022)
Coronavirus Disease 2019 Vaccinations in Patients With Chronic Liver Disease and Liver Transplant Recipients: An Update
Pimsiri Sripongpun et al.
FRONTIERS IN MEDICINE (2022)
Estimated Number of COVID-19 Infections, Hospitalizations, and Deaths Prevented Among Vaccinated Persons in the US, December 2020 to September 2021
Molly K. Steele et al.
JAMA NETWORK OPEN (2022)
SARS-CoV-2 vaccination and risk of severe COVID-19 outcomes in patients with autoimmune hepatitis
Cumali Efe et al.
JOURNAL OF AUTOIMMUNITY (2022)
Association between immunosuppressants and poor antibody responses to SARS-CoV-2 vaccines in patients with autoimmune liver diseases
Hu Li et al.
FRONTIERS IN IMMUNOLOGY (2022)
Variants of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Vaccine Effectiveness
SubbaRao Tulimilli et al.
VACCINES (2022)
Global Excess Mortality during COVID-19 Pandemic: A Systematic Review and Meta-Analysis
Weijing Shang et al.
VACCINES (2022)
Antibody development after COVID-19 vaccination in patients with autoimmune diseases in the Netherlands: a substudy of data from two prospective cohort studies
Laura Boekel et al.
LANCET RHEUMATOLOGY (2021)
Safety and immunogenicity of a SARS-CoV-2 inactivated vaccine in patients with chronic hepatitis B virus infection
Tiandan Xiang et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2021)
EASL position paper on the use of COVID-19 vaccines in patients with chronic liver diseases, hepatobiliary cancer and liver transplant recipients
Markus Cornberg et al.
JOURNAL OF HEPATOLOGY (2021)
Under-reporting of deaths limits our understanding of true burden of covid-19
Charles Whittaker et al.
BMJ-BRITISH MEDICAL JOURNAL (2021)
Characterization of SARS-CoV-2-Specific Humoral and Cellular Immune Responses Induced by Inactivated COVID-19 Vaccines in a Real-World Setting
Ziwei Li et al.
Frontiers in Immunology (2021)
Safety and immunogenicity of COVID-19 vaccination in patients with non-alcoholic fatty liver disease (CHESS2101): A multicenter study
Jitao Wang et al.
JOURNAL OF HEPATOLOGY (2021)
Immunogenicity and safety of the BNT162b2 mRNA COVID-19 vaccine in adult patients with autoimmune inflammatory rheumatic diseases and in the general population: a multicentre study
Victoria Furer et al.
ANNALS OF THE RHEUMATIC DISEASES (2021)
Efficacy and safety of an inactivated whole-virion SARS-CoV-2 vaccine (CoronaVac): interim results of a double-blind, randomised, placebo-controlled, phase 3 trial in Turkey
Mine Durusu Tanriover et al.
LANCET (2021)
Principles of Care for Patients with Liver Disease During the Coronavirus Disease 2019 (COVID-19) Pandemic: Position Statement of the Saudi Association for the Study of Liver Disease and Transplantation
Saleh A. Alqahtani et al.
ANNALS OF SAUDI MEDICINE (2020)
Impact of COVID-19 on the care of patients with liver disease: EASL-ESCMID position paper after 6 months of the pandemic
Tobias Boettler et al.
JHEP REPORTS (2020)
The role of plasma exchange in the management of autoimmune disorders
Elisabetta Zanatta et al.
BRITISH JOURNAL OF HAEMATOLOGY (2019)
Effect of statin use on the risk of medically attended acute respiratory illness among influenza vaccinated elderly
Hsien-Tsung Chiu et al.
VACCINE (2018)
Efficacy of plasma exchange and immunoadsorption in systemic lupus erythematosus and antiphospholipid syndrome: A systematic review
Andreas Kronbichler et al.
AUTOIMMUNITY REVIEWS (2016)
Immunoadsorption for connective tissue disease
B. Hohenstein et al.
ATHEROSCLEROSIS SUPPLEMENTS (2013)
Artificial liver support system in China: A review over the last 30 years
LJ Li et al.
THERAPEUTIC APHERESIS AND DIALYSIS (2006)